Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 4 44-4, 1998, Pages

  Chansel, Dominique ^a   Czekalski, Stanislas ^a   Vandermeersch, Sophie ^a   Ruffet, Emmanuel ^b   Fournié Zaluski, Marie Claude ^b   Ardaillou, Raymond ^a  

^a HÔPITAL TENON   (France)

^b CNRS   (France)

Author keywords

Aminopeptidase inhibitor; Aminopeptidase N; Angiotensin metabolites; Cytosolic calcium; Dipeptidylaminopeptidase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II [3-8]; DIPEPTIDYL PEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; DEGRADATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; GLOMERULUS; HORMONE METABOLISM; MALE; MESANGIUM CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT;

EID: 0031754276     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.4.f535     Document Type: Article

References (33)

1. Ahmad, S., and P. E. Ward. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J. Pharmacol. Exp. Therap. 252: 643-650, 1990.
2. Ardaillou, R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Current Opinion in Nephrology and Hypertension 6: 28-34, 1997.
3. Ardaillou, R., J. Sraer, D. Chansel, N. Ardaillou, and J. D. Sraer. The effects of angiotensin II on isolated glomeruli and cultured glomerular cells. Kidney Int. 31, Suppl.: S74-S80, 1987.
4. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-251, 1976.
5. Cattran, D. C., C. Greenwood, and S. Ritchie. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 23: 247-254, 1994.
6. Chansel, D., S. Czekalski, P. Pham, and R. Ardaillou. Characterization of angiotensin receptor subtypes in human glomeruli and mesangial cells. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F432-F441, 1992.
7. Chauvel, E., C. Llorens-Cortes, P. Coric, S. Wilk, B. P. Roques, and M. C. Fournié-Zaluski. Differential inhibition of aminopeptidase A and aminopeptidase N by new β aminothiols. J. Med. Chem. 37: 2950-2957, 1994.
8. Cherot, P., M. C. Fournié-Zaluski, and J. Laval. Purification and characterization of an enkephalin-degrading dipeptidyl-aminopeptidase from porcine brain. Biochemistry 25: 8184-8191, 1986.
9. Czekalski, S., D. Chansel, S. Vandermeersch, P. Ronco, and R. Ardaillou. Evidence for angiotensin IV receptors in human collecting duct cells. Kidney Int. 50: 1125-1131, 1996.
10. Dostal, D. E., T. Murahashi, and M. J. Peach. Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 15: 815-822, 1990.
11. Dulin, N. O., P. Ernsberger, D. J. Suciu, and J. G. Douglas. Rabbit renal epithelial angiotensin II receptors. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F776-F782, 1994.
12. Dulin, N. O., Z. T. Madhun, C. H. Chang, L. Berti-Mattera, D. Dickens, and J. G. Douglas. Angiotensin IV receptors and signaling in opossum kidney cells. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F644-F652, 1995.
13. Foidart, J., J. Sraer, F. Delarue, P. Mahieu, and R. Ardaillou. Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility. FEBS Lett. 121: 333-339, 1980.
14. Fournié-Zaluski, M. C., J. F. Hernandez, J. M. Soleilhac, N. Renwart, J. Peyroux, J. Xie, and B. P. Roques. Enkephalin-degrading enzyme inhibitors. Int. J. Peptide Protein Res. 33: 146-153, 1989.
15. Fournié-Zaluski, M. C., P. Coric, S. Turcaud, L. Bruetschy, E. Lucas, F. Noble, and B. P. Roques. Potent and systematically active aminopeptidase N inhibitors designed from active-site investigation. J. Med. Chem. 35: 1259-1266, 1992.
16. Hall, K. L., J. M. Hanesworth, A. E. Ball, G. P. Felgenhauer, H. L. Hosick, and J. W. Harding. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul. Pept. 44: 225-232, 1993.
17. 4-receptor system in the rat kidney. Am. J. Physiol. 274 (Renal Physiol. 43): F290-F299, 1998.
18. Hanesworth, J. M., M. F. Sardinia, L. T. Krebs, K. L. Hall, and J. W. Harding. Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J. Pharmacol. Exp. Therap. 266: 1036-1042, 1993.
19. 4 receptors: specificity, and distribution. Kidney Int. 46: 1510-1512, 1994.
20. Kerins, D. M., Q. Hao, and D. E. Vaughan. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J. Clin. Invest. 96: 2515-2530, 1995.
21. Kugler, P. On angiotensin-degrading aminopeptidases in the rat kidney. Adv. Anat. Embryol. Cell Biol. 76: 1-86, 1982.
22. Lafayette, R. A., G. Mayer, S. K. Park, and T. W. Meyer. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90: 766-771, 1992.
23. Malfroy, B., H. K. Fong, C. Gros, B. Giros, J. C. Schwartz, and R. Hellmiss. Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a superfamily of zinc-metallohydrolases. Biochem. Biophys. Res. Commun. 161: 236-241, 1989.
24. Nakamura, T., T. Takahashi, M. Fukui, I. Ebihara, S. Osada, Y. Tomino, and H. Koide. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J. Am. Soc. Nephrol. 5: 1492-1497, 1995.
25. Shimamura, M., T. Hazato, and T. Katayami. Purification and characterization of an enkephalin-degrading aminopeptidase from guinea pig serum. Biochim. Biophys. Acta 798: 8-13, 1984.
26. Stefanovic, V., P. Vlahovic, N. Ardaillou, P. Ronco, M. P. Nivez, and R. Ardaillou. Characterization and control of expression of cell surface aminopeptidase N activity in human mesangial glomerular cells. Cell Physiol. Biochem. 2: 57-68, 1992.
27. Stefanovic, V., P. Vlahovic, N. Ardaillou, P. Ronco, and R. Ardaillou. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 41: 1571-1580, 1992.
28. Swanson, G. N., J. M. Hanesworth, M. F. Sardinia, J. K. Coleman, J. W. Wright, K. L. Hall, A. V. Miller-Wing, J. W. Stobb, N. I. Cook, E. C. Harding, and J. W. Harding. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul. Pept. 40: 409-419, 1992.
29. Taniguchi, S., J. Marchetti, and F. Morel. Cytosolic free calcium concentration in single microdissected rat cortical collecting tubules. Pflügers Arch. 414: 125-133, 1989.
30. Troyanovska, M., L. Song, G. Jayaraman, and D. P. Healy. Expression of aminopeptidase A, an angiotensinase, in glomerular mesangial cells. Hypertension 27: 518-522, 1996.
31. Wang, L., M. Eberhard, and P. Erne. Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clinical Science. 88: 557-562, 1995.
32. Wright, J. W., A. V. Miller-Wing, M. J. Shaffer, C. Higginson, D. E. Wright, J. M. Hanesworth, and J. W. Harding. Angiotensin II (3-8) hippocampal binding: potential role in the facilitation of memory. Brain. Res. Bull. 32: 497-502, 1993.
33. Yamamoto, K., M. C. Chappell, B. Broshnihan, and C. Ferrario. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19: 692-696, 1992.